Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo; Drug: Tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: placebo; Drug: Fluticasone Furoate (FF)/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: simvastatin; Drug: Placebo
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Conditions: Cancer; Pain
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified August 2009
Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
Interventions: Drug: FF Inhalation Powder; Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: Placebo; Drug: FF Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI1744) Low; Drug: Olodaterol (BI1744) High; Drug: Tiotropium 18 mcg; Drug: Placebo (for Olodatero (BI1744)l); Drug: Placebo (for Tiotropium)
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: Chronic Bronchitis; Emphysema; Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719 250mcg; Drug: GSK573719 500mcg; Drug: GSK573719 125mcg; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Combivent Respimat; Drug: Combivent CFC-MDI; Drug: Atrovent HFA + Albuterol HFA
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GW642444 Inhalation Powder; Drug: FF/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Neoplasms; Pulmonary Disease, Chronic Obstructive; Heart Failure; Renal Disease
Interventions: Other: Outlook Attention Control; Other: Outlook Intervention
Sponsors: Duke University; National Institute of Nursing Research (NINR)
Recruiting - verified March 2010
Condition: Gulf War Syndrome
Interventions: Procedure: Lactulose Breath Test; Drug: Rifaximin; Drug: Placebo; Drug: Erythromycin ethylsuccinate (EES); Drug: Placebo; Drug: Bismuth subsalicylate
Sponsor: VA Merit Review, DOD (Department of Defense)
Recruiting - verified February 2010
Conditions: Chronic Sinusitis; Chronic Rhinosinusitis; Nasal Polyps
Intervention: Drug: Prednisone
Sponsor: Northwestern University
Recruiting - verified February 2010
Conditions: Mental Illness; Schizophrenia; Depression; PTSD; Bipolar Disorder
Interventions: Behavioral: Cognitive Remediation; Behavioral: Nintendo Brain Age
Sponsor: VA Connecticut Healthcare System
Recruiting - verified February 2010
Condition: Epilepsy
Interventions: Behavioral: COPE (Creating Opportunities for Parent Empowerment); Behavioral: Standard education
Sponsors: Children's Hospital Boston; National Institute of Nursing Research (NINR)
Recruiting - verified March 2010
Conditions: Chronic Sinusitis; Facial Pain Disorder; Depression
Interventions: Drug: escitalopram; Drug: placebo
Sponsors: University of Washington; National Institutes of Health (NIH); Forest Laboratories
Recruiting - verified March 2010
Conditions: Depression; Depressive Symptoms; Anxiety; Stress Disorders, Post-Traumatic; ICU Hospitalization; Care and Treatment in ICU
Interventions: Behavioral: Facilitator-Based intervention; Behavioral: Usual Care
Sponsors: University of Washington; National Institute of Nursing Research (NINR)
Recruiting - verified March 2010
Conditions: Sinusitis; Chronic Sinusitis
Interventions: Drug: Bacitracin; Procedure: Nasopore sponge soaked with saline
Sponsor: Lahey Clinic
Recruiting - verified March 2010
Conditions: Advanced Cancer; Chronic Obstructive Pulmonary Disease (COPD); Restrictive Lung Disease; Congestive Heart Failure; End Stage Liver Disease
Intervention: Behavioral: Training Program Intervention
Sponsors: University of Washington; National Institute of Nursing Research (NINR)
Recruiting - verified February 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Emphysema; Bronchitis, Chronic
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2009
Conditions: Bipolar Disorder; Cardiovascular Disease
Intervention: Behavioral: Chronic care model involving self-management educational sessions, care management for up to 1 year, and guideline dissemination
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Conditions: Chronic Obstructive Pulmonary Disease (COPD); Heart Failure
Interventions: Behavioral: Exercise adherence; Behavioral: Self-management- prevention of illness; Behavioral: Self-management of illness
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
All Categories ... Medical Conditions » ... Chronic Illness » ... Chronic Pain 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
